Prophylactic Options for Cardiotoxicity from 5-Fluorouracil
Author Information
Author(s): Cianci G, Morelli M F, Cannita K, Morese R, Ricevuto E, Di Rocco Z C, Porzio G, Lanfiuti Baldi P, Ficorella C
Primary Institution: Department of Medical Oncology, S. Salvatore Hospital, University of L'Aquila
Hypothesis
What are effective prophylactic treatments for cardiotoxicity associated with 5-fluorouracil?
Conclusion
Prophylactic treatment with nitroglycerin can help manage cardiotoxicity in patients receiving 5-fluorouracil.
Supporting Evidence
- 5-Fluorouracil can cause cardiac toxicity in a significant number of patients.
- Prophylactic nitroglycerin was effective in preventing angina-like symptoms in treated patients.
- The study highlights the need for awareness of cardiotoxicity associated with 5-fluorouracil.
Takeaway
Some cancer patients can get heart problems from a medicine called 5-fluorouracil, but using another medicine called nitroglycerin can help keep their hearts safe.
Methodology
The study describes three case reports of patients who experienced cardiotoxicity from 5-fluorouracil and the management strategies employed.
Limitations
The study is based on a small number of case reports, limiting the generalizability of the findings.
Participant Demographics
The average age of patients was 64 years, with none having a history of cardiac disease, but two had high blood pressure.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website